Joseph V. Lillis, MD
Dr. Joseph V. Lillis is a board-certified Dermatologist offering expertise in all areas of dermatology including skin cancer surveillance, medical dermatology, and Mohs Micrographic surgery. He is board-certified in Micrographic Dermatologic Surgery, is a fellow of the American Society for Mohs Surgery, and has performed over 10,000 Mohs surgery cases.
A graduate of Georgetown University Medical School, Dr. Lillis did his dermatology residency at Oregon Health & Science University in Portland, Oregon, where he served as Chief Resident during his final year.
He has since worked as an assistant clinical professor in the Division of Dermatology at The University of California San Diego Medical Center and in private practice at San Luis Dermatology & Laser Clinic in San Luis Obispo, California, and at Lake Loveland Dermatology in Loveland, Colorado. He has published several articles in peer-reviewed medical journals, serves as a manuscript reviewer for the British Journal of Dermatology, and has spoken at national and regional dermatology conferences. He is a fellow of the American Academy of Dermatology, a fellow of the American Society for Dermatologic Surgery, a member of the American Medical Association, and a member of the Colorado Dermatologic Society. He performs Mohs Surgery on-site in his Fort Collins location.
Raised in Loveland CO, Dr. Lillis returned home to Northern Colorado in July of 2014 and founded Colorado Dermatology Group in 2016.
When not at work, his favorite days are those spent hiking in Rocky Mountain National Park with his wife and two kids, skiing in Steamboat, and playing basketball and tennis with his kids.
BA: University of Notre Dame (1997-2001), Theology/Pre-professional Studies
MD: Georgetown University School of Medicine (2001-2005)
Internship: Legacy Health System, Portland Oregon (2005-2006), Internal Medicine
Residency: Oregon Health & Science University (2006-2009), Dermatology; Chief Resident: 2009
Specific areas of specialization:
Medical and surgical management of complex skin cancer patients, psoriasis, contact dermatitis, and hand eczema.